000 01266 a2200337 4500
005 20250513073018.0
264 0 _c19930824
008 199308s 0 0 eng d
022 _a0020-7136
024 7 _a10.1002/ijc.2910540604
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBamias, A
245 0 0 _aIntravesical administration of indium-111-labelled HMFG2 monoclonal antibody in superficial bladder carcinomas.
_h[electronic resource]
260 _bInternational journal of cancer
_cJul 1993
300 _a899-903 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Intravesical
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aCarcinoma
_xmetabolism
650 0 4 _aHumans
650 0 4 _aIndium Radioisotopes
_xadministration & dosage
650 0 4 _aRadioimmunotherapy
_xmethods
650 0 4 _aTissue Distribution
650 0 4 _aUrinary Bladder Neoplasms
_xmetabolism
700 1 _aBowles, M J
700 1 _aKrausz, T
700 1 _aWilliams, G
700 1 _aEpenetos, A A
773 0 _tInternational journal of cancer
_gvol. 54
_gno. 6
_gp. 899-903
856 4 0 _uhttps://doi.org/10.1002/ijc.2910540604
_zAvailable from publisher's website
999 _c8334678
_d8334678